Skip to content
Open access

Parietal Cortex Transcriptomics Refines Parkinson Disease GWAS Nomination and Highlights STAT3 as a Putative Upstream Glial Regulator

Aug 2026 · bioRxiv · 0 citations · 77 references
Biology Medicine

TL;DR

It is suggested that integrating disease-state transcriptomics with genetic prioritization can refine PD risk-gene nomination and uncover regulatory programs that may be missed by GWAS alone.

Read PDF

Similar papers

Open access Aug 2026

Brain single-cell transcriptome-informed Mendelian randomization identifies potential druggable therapeutic targets for Alzheimer's disease

A brain cell type-resolved genetic prioritization framework for AD is provided, nominating genetically supported candidate druggable targets and linking them to neurodegenerative and immune-related pathways.

Ren-Jun Huang, Li-Qing Guan, Yang Chen et al. · 0 citations
Open access Sep 2026

From genes to pathways: genetic convergence in early-onset Parkinsons disease in India

The first pathway resolved South Asian genetic profile and a framework for comparative studies across populations are provided, with different contributions from P/LP-associated and VUS associated gene sets.

R. Menon, A. I. Khan, D. Elangovan et al. · 0 citations
Aug 2026

Prioritizing Parkinson's disease risk-associated mitochondrial candidate genes via multi-omics integrative analysis.

BACKGROUND Mitochondrial dysfunction has been implicated in Parkinson's disease (PD), but the genetically regulated mitochondrial genes associated with PD risk remain incompletely defined. METHODS We conducted a summary-data-based genetic epidemiology study integrating summary-based Mendelian randomization (SMR), Het...

Yu-Sheng Zhu, Zihan Ye · 0 citations
Open access Aug 2026

Astrocytic HSP90AA1 Upregulation and Altered Synaptic Signaling in Parkinson’s Disease: Transcriptomic Screening and In Vivo Validation

Astrocytic upregulation of HSP90AA1 is associated with altered synapse-related intercellular communication patterns in the PD substantia nigra, potentially involving a predicted TP53 associated regulatory component.

Yi-Yuan Xu, Yanfeng Shi, Yan Li et al. · 0 citations
Open access Sep 2026

Integrative Proteogenomics and Single-Cell Transcriptomics Prioritize Candidate Causal Proteins and Therapeutic Targets in Age-Related Macular Degeneration

By combining large-scale plasma proteomic genetics with single-cell mapping and experimental validation, this study identifies a prioritized set of candidate causal proteins linking neuroimmune activation, vascular remodeling, and mitochondrial bioenergetics in AMD, providing candidate entry points for mechanistic and...

Lei Wen, Fang-Ran Li, Yuan Liu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.